Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Alzheimer disease (AD) is the most common neurodegenerative disorder worldwide and is at present, incurable. The accumulation of toxic amyloid-beta (Aβ) peptide aggregates in AD brain are thought to trigger the extensive synaptic loss and neurodegeneration linked to cognitive decline, an idea that underlies the amyloid hypothesis of AD etiology in both the familal (FAD) and sporadic forms of the disease. Genetic mutations causing FAD also result in the dysregulation of neuronal calcium (Ca2+) handling and may contribute to AD pathogenesis, an idea termed the calcium hypothesis of AD. Mutations in presenilin proteins account for majority of FAD cases. Presenilins function as catalytic subunit of γ-secretase involved in generation of Aβ peptide Recently, we discovered that presenilns function as low-conductance, passive ER Ca2+ leak channels, independent of γ-secretase activity. We further discovered that many FAD mutations in presenilins results in loss of ER Ca2+ leak function activity and Ca2+ overload in the ER. These results provided potential explanation for abnormal Ca2+ signaling observed in FAD cells with mutations in presenilns. The implications of these findings for understanding AD pathogenesis are discussed in this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 2×
“Since the discovery of their potential involvement in AD pathogenesis over 16 years ago (Sherrington et al., 1995), 182 mutations in PSEN1 and 14 in PSEN2 have been identified to be causative in FAD (www.molgen.ua.ac.be/ADMutations) (Cruts; Cruts and Van Broeckhoven, 1998).”
BackgroundAssociation of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · cited 2×
“…PS-FAD mutations result in a shift in the proteolysis of APP such that there is an increase in the production the hydrophobic, aggregation-prone 1–42 Aβ fragment, increasing Aβ42/40 ratio and contributing to Aβ plaque formation (De Strooper et al., 1998; Scheuner et al., 1996; Wolfe et al., 1999).”
BackgroundDeficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · cited 3×
“…PS-FAD mutations result in a shift in the proteolysis of APP such that there is an increase in the production the hydrophobic, aggregation-prone 1–42 Aβ fragment, increasing Aβ42/40 ratio and contributing to Aβ plaque formation (De Strooper et al., 1998; Scheuner et al., 1996; Wolfe et al., 1999).”
BackgroundAph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938
The amyloid hypothesis for Alzheimer’s disease: A critical reappraisal
Hardy, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06181.x · Cited by 814 · cited 3×
“Mutations in the genes encoding presenilin-1 (PSEN1), presenilin-2 (PSEN2) and amyloid precursor protein (APP) account for more than 50% of autosomal-dominant FAD cases (Bergmans and De Strooper, 2010; Bertram and Tanzi, 2008; Hardy, 2009; Hardy and Selkoe, 2002).”
BackgroundThirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747 · cited 1×
“Mutations in the genes encoding presenilin-1 (PSEN1), presenilin-2 (PSEN2) and amyloid precursor protein (APP) account for more than 50% of autosomal-dominant FAD cases (Bergmans and De Strooper, 2010; Bertram and Tanzi, 2008; Hardy, 2009; Hardy and Selkoe, 2002).”
BackgroundLinking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Small, S. A., & Duff, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.007 · Cited by 546 · cited 2×
“Mutations in the MAPT gene do not lead to AD but instead result in a variant of frontotemporal dementia (FTDP17) (Cruts and Van Broeckhoven, 2008; Hutton et al., 1998; Small and Duff, 2008).”
BackgroundAnnaert, W. G., Levesque, L., Craessaerts, K., Dierinck, I., Snellings, G., Westaway, D., George-Hyslop, P. S., Cordell, B., Fraser, P., & De Strooper, B. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.277 · Cited by 353
Correlating familial Alzheimer’s disease gene mutations with clinical phenotype
Ryan, N. S., & Rossor, M. N. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.92 · Cited by 176
Pathological Substrates of Cognitive Decline in Alzheimer’s Disease
Giannakopoulos, P., Kövari, E., Gold, G., von Gunten, A., Hof, P. R., & Bouras, C. (2009) · Frontiers of Neurology and Neuroscience · doi:10.1159/000197881 · Cited by 101 · cited 2×
“The key pathological hallmarks of AD are extensive neurodegeneration of the median temporal lobe (the hippocampus in particular), parietal lobe, select regions of the frontal cortex and cingulate gyrus (Giannakopoulos et al., 2009; Wenk, 2003); the presence of extracellular senile plaques composed of dense-core deposi…”
Background
Research works printed but not linked: 79
- Brookmeyer, 2007, Forecasting the global burden of Alzheimer's disease, Alzheimers Dement., 3, 186, 10.1016/j.jalz.2007.04.381 · DOI · Paper page
- Wenk, 2003, Neuropathologic changes in Alzheimer's disease, J. Clin. Psychiatry, 64, 7
- Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- Bergmans, 2010, gamma-secretases: from cell biology to therapeutic strategies, Lancet Neurol., 9, 215, 10.1016/S1474-4422(09)70332-1 · DOI · Paper page
- Cruts, 2008, Loss of progranulin function in frontotemporal lobar degeneration, Trends Genet., 24, 186, 10.1016/j.tig.2008.01.004 · DOI
- Cruts, 1998, Presenilin mutations in Alzheimer's disease, Hum. Mutat., 11, 183, 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.0.CO;2-J · DOI · Paper page
- Brown, 2000, Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans, Cell, 100, 391, 10.1016/S0092-8674(00)80675-3 · DOI · Paper page
- Urban, 2002, Conservation of intramembrane proteolytic activity and substrate specificity in prokaryotic and eukaryotic rhomboids, Curr. Biol., 12, 1507, 10.1016/S0960-9822(02)01092-8 · DOI
- Hass, 2009, Presenilin: RIP and beyond, Semin. Cell Dev. Biol., 20, 201, 10.1016/j.semcdb.2008.11.014 · DOI · Paper page
- Laudon, 2005, A nine-transmembrane domain topology for presenilin 1, J. Biol. Chem., 280, 35352, 10.1074/jbc.M507217200 · DOI · Paper page
- Spasic, 2006, Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway, J. Biol. Chem., 281, 26569, 10.1074/jbc.M600592200 · DOI · Paper page
- De Strooper, 1997, Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins, J. Biol. Chem., 272, 3590, 10.1074/jbc.272.6.3590 · DOI · Paper page
- Edbauer, 2003, Reconstitution of gamma-secretase activity, Nat. Cell Biol., 5, 486, 10.1038/ncb960 · DOI · Paper page
- Kimberly, 2003, Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2, Proc. Natl. Acad. Sci. U.S.A., 100, 6382, 10.1073/pnas.1037392100 · DOI · Paper page
- Lazarov, 2006, Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores, Proc. Natl. Acad. Sci. U.S.A., 103, 6889, 10.1073/pnas.0602321103 · DOI · Paper page
- Takasugi, 2003, The role of presenilin cofactors in the gamma-secretase complex, Nature, 422, 438, 10.1038/nature01506 · DOI · Paper page
- Thinakaran, 1996, Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo, Neuron, 17, 181, 10.1016/S0896-6273(00)80291-3 · DOI · Paper page
- Wolfe, 1999, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity, Nature, 398, 513, 10.1038/19077 · DOI · Paper page
- Yu, 1998, The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin, J. Biol. Chem., 273, 16470, 10.1074/jbc.273.26.16470 · DOI · Paper page
- Demuro, 2010, Calcium signaling and amyloid toxicity in Alzheimer disease, J. Biol. Chem., 285, 12463, 10.1074/jbc.R109.080895 · DOI · Paper page
- Stutzmann, 2007, The pathogenesis of Alzheimers disease is it a lifelong “calciumopathy”?, Neuroscientist, 13, 546, 10.1177/1073858407299730 · DOI · Paper page
- Supnet, 2010, The dysregulation of intracellular calcium in Alzheimer disease, Cell Calcium, 47, 183, 10.1016/j.ceca.2009.12.014 · DOI · Paper page
- Ito, 1994, Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 91, 534, 10.1073/pnas.91.2.534 · DOI · Paper page
- Etcheberrigaray, 1998, Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families, Neurobiol. Dis., 5, 37, 10.1006/nbdi.1998.0176 · DOI · Paper page
- Khachaturian, 1989, Calcium, membranes, aging, and Alzheimer's disease. Introduction and overview, Ann. N.Y. Acad. Sci., 568, 1, 10.1111/j.1749-6632.1989.tb12485.x · DOI · Paper page
- Supnet, 2010, Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease, J. Alzheimers Dis., 20, S487, 10.3233/JAD-2010-100306 · DOI · Paper page
- Chan, 2000, Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons, J. Biol. Chem., 275, 18195, 10.1074/jbc.M000040200 · DOI · Paper page
- Lee, 2006, PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release, FASEB J., 20, 151
- Smith, 2005, Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease, J. Neurochem., 94, 1711, 10.1111/j.1471-4159.2005.03332.x · DOI · Paper page
- Chakroborty, 2009, Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice, J. Neurosci., 29, 9458, 10.1523/JNEUROSCI.2047-09.2009 · DOI · Paper page
- Goussakov, 2010, NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice, J. Neurosci., 30, 12128, 10.1523/JNEUROSCI.2474-10.2010 · DOI · Paper page
- Stutzmann, 2006, Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice, J. Neurosci., 26, 5180, 10.1523/JNEUROSCI.0739-06.2006 · DOI · Paper page
- Leissring, 1999, Presenilin-2 mutations modulate amplitude and kinetics of inositol 1,4,5-trisphosphate-mediated calcium signals, J. Biol. Chem., 274, 32535, 10.1074/jbc.274.46.32535 · DOI · Paper page
- Akbari, 2004, Presenilin regulates capacitative calcium entry dependently and independently of gamma-secretase activity, Biochem. Biophys. Res. Commun., 322, 1145, 10.1016/j.bbrc.2004.07.136 · DOI
- Giacomello, 2005, Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia, Neurobiol. Dis., 18, 638, 10.1016/j.nbd.2004.10.016 · DOI
- Herms, 2003, Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein, J. Biol. Chem., 278, 2484, 10.1074/jbc.M206769200 · DOI · Paper page
- Leissring, 2000, Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice, J. Cell Biol., 149, 793, 10.1083/jcb.149.4.793 · DOI · Paper page
- Yoo, 2000, Presenilin-mediated modulation of capacitative calcium entry, Neuron, 27, 561, 10.1016/S0896-6273(00)00066-0 · DOI · Paper page
- Zatti, 2004, The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores, Neurobiol. Dis., 15, 269, 10.1016/j.nbd.2003.11.002 · DOI · Paper page
- Zhang, 2010, Role of presenilins in neuronal calcium homeostasis, J. Neurosci., 30, 8566, 10.1523/JNEUROSCI.1554-10.2010 · DOI · Paper page
- Cheung, 2010, Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons, Sci. Signal., 3, ra22, 10.1126/scisignal.2000818 · DOI · Paper page
- Cheung, 2008, Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP(3) receptor channel gating, Neuron, 58, 871, 10.1016/j.neuron.2008.04.015 · DOI · Paper page
- Green, 2008, SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production, J. Cell Biol., 181, 1107, 10.1083/jcb.200706171 · DOI · Paper page
- Tu, 2006, Presenilins form ER calcium leak channels, a function disrupted by mutations linked to familial Alzheimer's disease, Cell, 126, 981, 10.1016/j.cell.2006.06.059 · DOI · Paper page
- Nelson, 2010, Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes, J. Alzheimers Dis., 21, 781, 10.3233/JAD-2010-100159 · DOI · Paper page
- Nelson, 2007, Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1, J. Clin. Invest., 117, 1230, 10.1172/JCI30447 · DOI · Paper page
- Sato, 2006, Structure of the catalytic pore of gamma-secretase probed by the accessibility of substituted cysteines, J. Neurosci., 26, 12081, 10.1523/JNEUROSCI.3614-06.2006 · DOI · Paper page
- Sato, 2008, The C-terminal PAL motif and transmembrane domain 9 of presenilin 1 are involved in the formation of the catalytic pore of the gamma-secretase, J. Neurosci., 28, 6264, 10.1523/JNEUROSCI.1163-08.2008 · DOI · Paper page
- Tolia, 2006, Contribution of presenilin transmembrane domains 6 and 7 to a water-containing cavity in the {gamma}-secretase complex, J. Biol. Chem., 281, 27633, 10.1074/jbc.M604997200 · DOI · Paper page
- Tolia, 2008, Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of gamma-secretase, J. Biol. Chem., 283, 19793, 10.1074/jbc.M802461200 · DOI · Paper page
- Akabas, 1994, Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the alpha subunit, Neuron, 13, 919, 10.1016/0896-6273(94)90257-7 · DOI · Paper page
- Akabas, 1992, Acetylcholine receptor channel structure probed in cysteine-substitution mutants, Science, 258, 307, 10.1126/science.1384130 · DOI · Paper page
- Sobhanifar, 2010, Structural investigation of the C-terminal catalytic fragment of presenilin 1, Proc. Natl. Acad. Sci. U.S.A., 107, 9644, 10.1073/pnas.1000778107 · DOI
- Nelson, 2011, Mutagenesis mapping of presenilin 1 calcium leak conductance pore, J. Biol. Chem., 10.1074/jbc.M111.243063 · DOI · Paper page
- Herl, 2006, Detection of presenilin-1 homodimer formation in intact cells using fluorescent lifetime imaging microscopy, Biochem. Biophys. Res. Commun., 340, 668, 10.1016/j.bbrc.2005.12.063 · DOI
- Cervantes, 2001, Homodimerization of presenilin N-terminal fragments is affected by mutations linked to Alzheimer's disease, FEBS Lett., 505, 81, 10.1016/S0014-5793(01)02785-5 · DOI
- Cervantes, 2004, Functional implications of the presenilin dimerization: reconstitution of gamma-secretase activity by assembly of a catalytic site at the dimer interface of two catalytically inactive presenilins, J. Biol. Chem., 279, 36519, 10.1074/jbc.M404832200 · DOI · Paper page
- Hebert, 2003, Dimerization of presenilin-1 in vivo: suggestion of novel regulatory mechanisms leading to higher order complexes, Biochem. Biophys. Res. Commun., 301, 119, 10.1016/S0006-291X(02)02984-4 · DOI
- Takagi, 2010, Participation of transmembrane domain 1 of presenilin 1 in the catalytic pore structure of the {gamma}-secretase, J. Neurosci., 30, 15943, 10.1523/JNEUROSCI.3318-10.2010 · DOI · Paper page
- Oh, 2006, Protease digestion indicates that endogenous presenilin 1 is present in at least two physical forms, Biochem. Biophys. Res. Commun., 346, 330, 10.1016/j.bbrc.2006.05.127 · doi:10.1016/j.bbrc.2006.05.127
- Placanica, 2010, Characterization of an atypical gamma-secretase complex from hematopoietic origin, Biochemistry, 49, 2796, 10.1021/bi901388t · DOI
- Larner, 2006, Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene, J. Neurol., 253, 139, 10.1007/s00415-005-0019-5 · DOI · Paper page
- Shepherd, 2009, Variations in the neuropathology of familial Alzheimer's disease, Acta Neuropathol., 118, 37, 10.1007/s00401-009-0521-4 · DOI
- Houlden, 2000, Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations, Ann. Neurol., 48, 806, 10.1002/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F · DOI · Paper page
- Kwok, 1997, Two novel (M233 T and R278 T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype, Neuroreport, 8, 1537, 10.1097/00001756-199704140-00043 · DOI · Paper page
- Crook, 1998, A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1, Nat. Med., 4, 452, 10.1038/nm0498-452 · DOI · Paper page
- Verkkoniemi, 2001, Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype, J. Neuropathol. Exp. Neurol., 60, 483, 10.1093/jnen/60.5.483 · DOI · Paper page
- Karlstrom, 2008, Variable phenotype of Alzheimer's disease with spastic paraparesis, J. Neurochem., 104, 573, 10.1111/j.1471-4159.2007.05038.x · DOI · Paper page
- Tabira, 2002, Alzheimer's disease with spastic paresis and cotton wool type plaques, J. Neurosci. Res., 70, 367, 10.1002/jnr.10392 · DOI · Paper page
- Ataka, 2004, A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis, Arch. Neurol., 61, 1773, 10.1001/archneur.61.11.1773 · DOI · Paper page
- Halliday, 2005, Pick bodies in a family with presenilin-1 Alzheimer's disease, Ann. Neurol., 57, 139, 10.1002/ana.20366 · DOI
- Le, 2001, Cotton wool plaques in non-familial late-onset Alzheimer disease, J. Neuropathol. Exp. Neurol., 60, 1051, 10.1093/jnen/60.11.1051 · DOI
- Brooks, 2003, Alzheimer's disease with spastic paraparesis and ‘cotton wool’ plaques: two pedigrees with PS-1 exon 9 deletions, Brain, 126, 783, 10.1093/brain/awg084 · DOI · Paper page
- Jacquemont, 2002, Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease, J. Med. Genet., 39, E2, 10.1136/jmg.39.2.e2 · DOI
- Takao, 2002, A novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum, Acta Neuropathol., 104, 155, 10.1007/s00401-002-0536-6 · DOI
- Foster, 2007, Calcium homeostasis and modulation of synaptic plasticity in the aged brain, Aging Cell, 6, 319, 10.1111/j.1474-9726.2007.00283.x · DOI · Paper page
- Gant, 2006, Early and simultaneous emergence of multiple hippocampal biomarkers of aging is mediated by Ca2+-induced Ca2+ release, J. Neurosci., 26, 3482, 10.1523/JNEUROSCI.4171-05.2006 · DOI · Paper page
- Toescu, 2007, The importance of being subtle: small changes in calcium homeostasis control cognitive decline in normal aging, Aging Cell, 6, 267, 10.1111/j.1474-9726.2007.00296.x · DOI · Paper page
- Bezprozvanny, 2009, Calcium signaling and neurodegenerative diseases, Trends Mol. Med., 15, 89, 10.1016/j.molmed.2009.01.001 · DOI · Paper page
Cited by
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Salminen, A., Kaarniranta, K., Kauppinen, A., Ojala, J., Haapasalo, A., Soininen, H., & Hiltunen, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.002 · Cited by 364
The amyloid cascade hypothesis: an updated critical review
Kepp, K. P., Robakis, N. K., Høilund-Carlsen, P. F., Sensi, S. L., & Vissel, B. (2023) · Brain · doi:10.1093/brain/awad159 · Cited by 284
Autophagic/lysosomal dysfunction in Alzheimer’s disease
Orr, M. E., & Oddo, S. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt217 · Cited by 199
ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease
Lane-Donovan, C., & Herz, J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.12.001 · Cited by 157
“In general terms, there is an important role for presenilins in intracellular Ca2+ stores, which have been discussed in depth in other reviews [58].”
Background
Metadata
- Authors
- Supnet, C., & Bezprozvanny, I.
- Venue
- Cell Calcium
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 50
- Issue
- 3
- Pages
- 303-309
- ISSN
- 0143-4160 (ISSN-L)
- OpenAlex
- W2032419750
- Cited by
- 95
- References
- 12
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.